Neuropharmacology and Drug Interactions in Clinical Practice

Summary: Absorption, distribution, and clearance are key pharmacokinetic principles. These parameters can be highly variable among patients and among compounds, and are factors that must be considered in the wide variability in response to medications. Current antiepileptic drugs (AEDs) present many challenges in their administration. However, understanding and utilizing pharmacokinetic principles can assist the clinician in the appropriate optimization of AEds.

[1]  I. Leppik,et al.  The effect of felbamate on valproic acid disposition , 1994, Clinical pharmacology and therapeutics.

[2]  D. Israel,et al.  Warfarin-Felbamate Interaction: First Report , 1994, The Annals of pharmacotherapy.

[3]  V. Trudeau,et al.  Lack of serious toxicity following gabapentin overdose , 1994, Neurology.

[4]  M. Zupanc,et al.  Potential Pharmacokinetic Interaction between Felbamate and Phenobarbital , 1994, The Annals of pharmacotherapy.

[5]  G. Holmes,et al.  Discontinuation of Phenytoin and Carbamazepine in Patients Receiving Felbamate , 1991, Epilepsia.

[6]  D. Haidukewych,et al.  Derivation and Evaluation of an Equation for Prediction of Free Phenytoin Concentration in Patients Co‐Medicated with Valproic Acid , 1989, Therapeutic drug monitoring.

[7]  A. Barr,et al.  Effect of food on the serum concentration profile of entericcoated valproic acid , 1988, Neurology.

[8]  E. Armstrong,et al.  Influence of Enteral Feedings on Phenytoin Sodium Absorption from Capsules , 1988, Drug intelligence & clinical pharmacy.

[9]  W. Fitzsimmons,et al.  Effect of Two Administration Schedules of an Enteral Nutrient Formula on Phenytoin Bioavailability , 1987, Epilepsia.

[10]  J. Cramer,et al.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. , 1985, The New England journal of medicine.

[11]  D. Greenblatt,et al.  Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam. , 1983, Journal of pharmaceutical sciences.

[12]  L. Bauer.  Interference of oral phenytoin absorption by continuous nasogastric feedings , 1982, Neurology.

[13]  I. Patel,et al.  Valproic acid dosage and plasma protein binding and clearance , 1980, Clinical pharmacology and therapeutics.

[14]  D. Greenblatt,et al.  Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. , 1980, Journal of pharmaceutical sciences.

[15]  D. Greenblatt,et al.  Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans , 1979 .

[16]  J. Cramer,et al.  Valproic Acid: In Vitro Plasma Protein Binding and Interaction with Phenytoin , 1979, Therapeutic drug monitoring.

[17]  J. Cramer,et al.  Valproic acid in epilepsy: Clinical and pharmacological effects , 1978, Annals of neurology.

[18]  A. Richens,et al.  SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSY , 1975, The Lancet.